Frontiers in Microbiology,
Год журнала:
2023,
Номер
14
Опубликована: Апрель 14, 2023
Antibiotic-associated
diarrhea
(AAD)
is
a
common
side
effect
during
antibiotic
treatment,
which
can
cause
dysbacteriosis
of
the
gut
microbiota.
Previous
studies
have
shown
beneficial
effects
in
AAD
treatment
with
Bifidobacterium
lactis
XLTG11,
Lactobacillus
casei
Zhang,
plantarum
CCFM8661,
and
rhamnosus
Probio-M9.
However,
no
been
conducted
on
immunomodulatory
protective
intestinal
barrier
function
four
complex
probiotics.
The
aim
our
study
to
investigate
alleviation
probiotics
ampicillin-induced
AAD.Thirty-six
BALB/c
mice
were
randomly
divided
into
six
groups:
normal
control
group
(NC),
model
(MC),
low-,
medium-,
high-dose
groups
(LD,
MD,
HD),
positive
drug
(Bifico,
1
×
107
cfu)
(PDC;
Bifico,
also
known
as
Triple
Live
Capsule,
composed
longum,
acidophilus,
Enterococcus
faecalis).
An
was
established
by
intragastric
administration
ampicillin,
gavage
different
doses
Bifico.
weight
gain,
fecal
water
content,
loose
stool
grade,
permeability,
total
protein
albumin
levels,
barrier,
cytokine
microbiota
determined.The
results
showed
that
significantly
decreased
ileum
tissue
damage.
Their
application
increased
SIgA,
TP,
ALB
levels.
Additionally,
levels
pro-inflammatory
cytokines
those
anti-inflammatory
cytokines.
Meanwhile,
mRNA
expression
ZO-1,
occludin,
claudin-1,
MUC2
upregulated
probiotic-treated
group.
Furthermore,
diversity
modulated
changes
composition
caused
ampicillin.
At
phylum
level,
abundance
Proteobacteria
HD
lower
than
MC
group,
whereas
Bacteroidetes
higher.
genus
abundances
Klebsiella
Parabacteroides
lower,
Bacteroides,
Muribaculaceae,
higher
Moreover,
Spearman's
correlation
analysis
found
several
specific
correlated
AAD-related
indicators.We
improved
diarrhea-related
indexes,
regulated
diversity,
barrier-related
genes,
preserved
function,
relieved
inflammation
injury,
thereby
effectively
improving
AAD-associated
symptoms.
Graphical
Abstract.
Cells,
Год журнала:
2024,
Номер
13(5), С. 444 - 444
Опубликована: Март 3, 2024
Inflammatory
bowel
disease
(IBD)
refers
to
a
cluster
of
intractable
gastrointestinal
disorders
with
an
undetermined
etiology
and
lack
effective
therapeutic
agents.
Amygdalin
(Amy)
is
glycoside
extracted
from
the
seeds
apricot
other
Rosaceae
plants
it
exhibits
wide
range
pharmacological
properties.
Here,
effects
mechanisms
Amy
on
colitis
were
examined
via
16S
rRNA
sequencing,
ELISA,
transmission
electron
microscopy,
Western
blot,
immunofluorescence.
The
results
showed
that
administration
remarkably
attenuated
signs
(reduced
body
weight,
increased
activity
index,
shortened
colon
length)
histopathological
damage
in
dextran
sodium
sulfate
(DSS)-challenged
mice.
Further
studies
revealed
significantly
diminished
DSS-triggered
gut
barrier
dysfunction
by
lowering
pro-inflammatory
mediator
levels,
inhibiting
oxidative
stress,
reducing
intestinal
epithelial
apoptosis
ferroptosis.
Notably,
lowered
TLR4
expression
phosphorylation
proteins
related
NF-κB
MAPK
pathways.
Furthermore,
modulated
balance
flora,
including
selective
rise
abundance
S24-7
decline
Allobaculum,
Oscillospira,
Bacteroides,
Sutterella,
Shigella.
In
conclusion,
can
alleviate
colitis,
which
provides
data
support
utility
combating
IBD.
Frontiers in Immunology,
Год журнала:
2022,
Номер
13
Опубликована: Сен. 23, 2022
Inflammatory
bowel
disease
(IBD)
is
characterized
by
chronic
and
relapsing
inflammation
of
gastrointestinal
tract,
with
steadily
increased
incidence
prevalence
worldwide.
Although
the
precise
pathogenesis
remains
unclear,
gut
microbiota,
bile
acids
(BAs),
aberrant
immune
response
play
essential
roles
in
development
IBD.
Lately,
dysbiosis
including
certain
decreased
beneficial
bacteria
pathogens
BAs
metabolism
have
been
reported
The
inhabited
human
critical
functions
BA
biotransformation.
Patients
active
IBD
elevated
primary
conjugated
secondary
BAs,
accompanied
impaired
transformation
activities
(mainly
deconjugation
7α-dehydroxylation)
microbiota.
Probiotics
exhibited
positive
effects
different
mechanisms
therapy
This
review
discussed
effectiveness
probiotics
clinical
animal
model
studies
that
might
involve
microbiota-BAs
axis.
More
importantly,
possible
on
regulating
axis
were
elucidated,
which
we
focused
containing
salt
hydrolase
or
BA-inducible
enzymes
at
genus/species
level
participate
Furthermore,
exerted
activation
BA-activated
receptors
intestinal
immunity
also
summarized,
partially
explain
protect
Therefore,
this
will
provide
new
insights
into
a
better
understanding
targeting
Nutrients,
Год журнала:
2023,
Номер
15(22), С. 4813 - 4813
Опубликована: Ноя. 17, 2023
The
incidence
of
ulcerative
colitis
(UC)
is
increasing
annually.
There
are
few
treatments
for
UC
patients,
and
some
drugs
have
serious
side
effects.
Sea
cucumber
peptide
(SCP)
has
anti-inflammatory,
antioxidant
other
biological
activities,
various
sea
species
in
pharmaceutical
development.
However,
relevant
studies
on
the
effects
SCP
progression
still
lacking.
In
this
study,
a
mouse
model
acute
was
induced
by
3%
dextran
sulfate
(DSS),
effect
500
mg/kg
investigated.
results
showed
that
can
alleviate
DSS-induced
colon
damage
intestinal
barrier
damage.
significantly
inhibited
expression
inflammatory
factors
oxidative
stress
mice.
reversed
microbiota
dysregulation
DSS,
growth
Sutterella,
Prevotella_9
Escherichia-Shigella
harmful
bacteria,
increased
abundance
Lachnospiraceae_NK4A136_group.
At
same
time,
treatment
LPS-induced
polarization
M1
macrophages,
which
may
be
mediated
two
monopeptides,
IPGAPGVP
TGPIGPPGSP,
via
FPR2.
conclusion,
protect
against
modulating
composition
inhibiting
macrophages.
Frontiers in Microbiology,
Год журнала:
2023,
Номер
14
Опубликована: Апрель 14, 2023
Antibiotic-associated
diarrhea
(AAD)
is
a
common
side
effect
during
antibiotic
treatment,
which
can
cause
dysbacteriosis
of
the
gut
microbiota.
Previous
studies
have
shown
beneficial
effects
in
AAD
treatment
with
Bifidobacterium
lactis
XLTG11,
Lactobacillus
casei
Zhang,
plantarum
CCFM8661,
and
rhamnosus
Probio-M9.
However,
no
been
conducted
on
immunomodulatory
protective
intestinal
barrier
function
four
complex
probiotics.
The
aim
our
study
to
investigate
alleviation
probiotics
ampicillin-induced
AAD.Thirty-six
BALB/c
mice
were
randomly
divided
into
six
groups:
normal
control
group
(NC),
model
(MC),
low-,
medium-,
high-dose
groups
(LD,
MD,
HD),
positive
drug
(Bifico,
1
×
107
cfu)
(PDC;
Bifico,
also
known
as
Triple
Live
Capsule,
composed
longum,
acidophilus,
Enterococcus
faecalis).
An
was
established
by
intragastric
administration
ampicillin,
gavage
different
doses
Bifico.
weight
gain,
fecal
water
content,
loose
stool
grade,
permeability,
total
protein
albumin
levels,
barrier,
cytokine
microbiota
determined.The
results
showed
that
significantly
decreased
ileum
tissue
damage.
Their
application
increased
SIgA,
TP,
ALB
levels.
Additionally,
levels
pro-inflammatory
cytokines
those
anti-inflammatory
cytokines.
Meanwhile,
mRNA
expression
ZO-1,
occludin,
claudin-1,
MUC2
upregulated
probiotic-treated
group.
Furthermore,
diversity
modulated
changes
composition
caused
ampicillin.
At
phylum
level,
abundance
Proteobacteria
HD
lower
than
MC
group,
whereas
Bacteroidetes
higher.
genus
abundances
Klebsiella
Parabacteroides
lower,
Bacteroides,
Muribaculaceae,
higher
Moreover,
Spearman's
correlation
analysis
found
several
specific
correlated
AAD-related
indicators.We
improved
diarrhea-related
indexes,
regulated
diversity,
barrier-related
genes,
preserved
function,
relieved
inflammation
injury,
thereby
effectively
improving
AAD-associated
symptoms.
Graphical
Abstract.